Glioblastoma is a highly aggressive brain tumor with about a 10% 5-year survival rate. The debilitating disease affects roughly 3 people per 100,000. According to the Mayo Clinic Comprehensive Cancer ...

Context Explanation

Nanowerk: Targeted nanoparticle therapy doubled survival rates in aggressive brain cancer models Targeted liposomal nanoparticles successfully cross the blood brain barrier to treat glioblastoma and doubled survival rates in preclinical brain cancer models. The study by researchers from the Royal College of Surgeons in Ireland and several hospitals also found females with brain tumours have better survival rates than males. Nasdaq: Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals Labroots: Novel Combination Regimen with Electric Field Therapy Improves Brain Cancer Survival MSN: Focused ultrasound with chemotherapy shows survival benefit for brain cancer patients, clinical trial finds